226 related articles for article (PubMed ID: 31584850)
1. CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy.
Beck JD; Birtel M; Haefner E; Keil IS; Reidenbach D; Salomon N; Yildiz IG; Diken M
Hum Vaccin Immunother; 2020 Apr; 16(4):808-815. PubMed ID: 31584850
[No Abstract] [Full Text] [Related]
2. CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16
Beck J; Birtel M; Reidenbach D; Salomon N; Diken M
Hum Vaccin Immunother; 2018; 14(12):2864-2873. PubMed ID: 30111232
[TBL] [Abstract][Full Text] [Related]
3. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
[No Abstract] [Full Text] [Related]
4. CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy.
Berger PA; Freitag J; Linkenbach SC; Merz L; Schork M; Thevissen S; Yildiz I; Beck JD
Hum Vaccin Immunother; 2022 Nov; 18(6):2124785. PubMed ID: 36222759
[TBL] [Abstract][Full Text] [Related]
5. CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
Billmeier A; Khinvasara K; Lang F; Mohr J; Reidenbach D; Schork M; Yildiz I; Diken M
Hum Vaccin Immunother; 2022 Dec; 18(1):2024416. PubMed ID: 35130105
[TBL] [Abstract][Full Text] [Related]
6. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
[No Abstract] [Full Text] [Related]
7. CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.
Kranz LM; Birtel M; Hilscher L; Grunwitz C; Petschenka J; Vascotto F; Vormehr M; Voss RH; Kreiter S; Diken M
Hum Vaccin Immunother; 2016 Nov; 12(11):2805-2812. PubMed ID: 27435168
[No Abstract] [Full Text] [Related]
8. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy.
Kranz LM; Birtel M; Krienke C; Grunwitz C; Petschenka J; Reuter KC; van de Roemer N; Vascotto F; Vormehr M; Kreiter S; Diken M
Hum Vaccin Immunother; 2016; 12(1):213-21. PubMed ID: 26186022
[No Abstract] [Full Text] [Related]
9. Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
Theelen J; Braun J; Hörzer H; Kloke BP; Ott M; Pizzitola I; Schirmer U; Miller M
Cancer Immunol Immunother; 2017 May; 66(5):673-681. PubMed ID: 28251274
[No Abstract] [Full Text] [Related]
10. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
[TBL] [Abstract][Full Text] [Related]
11. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
[TBL] [Abstract][Full Text] [Related]
12. Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.
Gulley JL; Repasky EA; Wood LS; Butterfield LH
J Immunother Cancer; 2017 Jul; 5(1):55. PubMed ID: 28716068
[TBL] [Abstract][Full Text] [Related]
13. CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany.
Singh SK; Laske K; Gouttefangeas C; Britten CM; Welters MJ
Cancer Immunol Immunother; 2011 Mar; 60(3):443-50. PubMed ID: 21104411
[No Abstract] [Full Text] [Related]
14. New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31
Adusumilli PS; Cha E; Cornfeld M; Davis T; Diab A; Dubensky TW; Evans E; Grogan JL; Irving BA; Leidner RS; Olwill SA; Soon-Shiong P; Triebel F; Tuck D; Bot A; Dansey RD; Drake CG; Freeman GJ; Ibrahim R; Patel S; Chen DS
J Immunother Cancer; 2017; 5():50. PubMed ID: 28649381
[TBL] [Abstract][Full Text] [Related]
15. [Personalized modulation of tumor microimmune microenvironment for the development of effective combination immunotherapy].
Kawakami Y
Rinsho Ketsueki; 2018; 59(7):939-944. PubMed ID: 30078806
[TBL] [Abstract][Full Text] [Related]
16. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
Hobohm K; Seppmann T; Britten CM; Hoff H
Cancer Immunol Immunother; 2012 Jan; 61(1):137-43. PubMed ID: 22048716
[No Abstract] [Full Text] [Related]
17. CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy.
Dallmann J; Freitag J; Jung C; Khinvasara K; Merz L; Peters D; Schork M; Beck JD
Immunooncol Technol; 2023 Dec; 20():100397. PubMed ID: 37876518
[TBL] [Abstract][Full Text] [Related]
18. Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
Kloke BP; Rae R; Mahr A; Burkhardt UE; Kvistborg P; Britten CM
Cancer Immunol Immunother; 2014 Jul; 63(7):749-55. PubMed ID: 24190545
[No Abstract] [Full Text] [Related]
19. Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.
Bellone M; Brevi A; Bronte V; Dusi S; Ferrucci PF; Nisticò P; Rosato A; Russo V; Sica A; Toietta G; Colombo MP
Cancer Immunol Immunother; 2022 Jul; 71(7):1787-1794. PubMed ID: 35034143
[No Abstract] [Full Text] [Related]
20. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.
Bellone M; Bregni M; Bronte V; Ugel S; Ferrucci PF; Di Nicola M; Nisticò P; Zuccolotto G; Rosato A; Russo V; Sica A; Colombo MP
Cancer Immunol Immunother; 2022 Jul; 71(7):1777-1786. PubMed ID: 34755203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
